Cipla Rumored Frontrunner For Wockhardt Deal

In ‘Pole Position’ To Buy Parts Of Debt-Laden Wockhardt

Cipla is reportedly leading the pack to acquire business divisions of debt-laden Wockhardt in a transaction that could be worth hundreds of millions of dollars and would boost the Mumbai-based company’s domestic presence.

Wockhardt
Cipla has emerged as the frontrunner to pick up parts of Wockhardt • Source: Shutterstock

Cipla, Indian’s third-largest drug company, is the frontrunner to acquire various business divisions of ailing Wockhardt, according to a report from financial portal Moneycontrol. “Cipla is in pole position currently and is leading the race to buy a clutch of Wockhardt's business divisions which have been put on the block," Moneycontrol quoted an unidentified source as saying.

Cipla, led by Yusuf Hamied, “can achieve further scale and boost its domestic presence with this transaction. The discussions are...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business